Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake

expresspharmaJuly 31, 2020

Tag: Tata Capital , Biocon , Investment

PharmaSources Customer Service